https://www.sciencedaily.com/releases/2025/11/251116105627.htm
0
0
54 words
0
Comments
GLP-1 drugs like tirzepatide and semaglutide offer powerful weight-loss effects but come with unanswered questions about long-term safety, side effects, and global accessibility. Researchers stress the need for independent studies before these treatments can …
You are the first to view
Create an account or login to join the discussion